Abstract
Polycystic ovary syndrome (PCOS) is the most common metabolic and endocrine disorder in women. However, there is no agreement concerning how to diagnose and treat PCOS worldwide. Three practice guidelines or consensuses, including consensus from the European Society of Human Reproduction and Embryology (ESHRE)/the American Society for Reproductive Medicine (ASRM) in Rotterdam, diagnosis criteria and consensus in China, and clinical practice guideline from the Endocrine Society (ES) in the United States are widely recognized. The present paper may provide some guidance for clinical practice based on a comparative analysis of the above three practice guidelines or consensuses.
中文概要
通过比较欧洲人类生殖和胚胎学会和美国生殖医 学协会联合发表的鹿特丹共识、中国的多囊卵巢 综合征诊治标准专家共识和美国内分泌学会的临 床实践指南,分析了不同指南对育龄期、青春期 和围绝经期多囊卵巢综合症诊断标准的差异,概 括了多囊卵巢综合征临床治疗的主要方面,同时 提出了一些诊治方面的新进展及今后需要进一步 关注的问题。在多囊卵巢综合征的诊断上,对育 龄期女性的标准三大指南略有不同,而对青春期 和围绝经期女性的标准尚待完善。多囊卵巢综合 征的治疗主要围绕肥胖、月经失调、高雄激素血症、 胰岛素抵抗、不孕、青春期、心理干预等来进行, 各大指南各有侧重。由于不同种族的多囊卵巢综 合征的临床表现差异较大,需要尽早建立具有种 族特异性的指南来改善诊疗过度或不足的情况。
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amr N, Abdel-Rahim HE, 2015. The effect of chromium supplementation on polycystic ovary syndrome in adolescents. J Pediatr Adolesc Gynecol, 28(2):114–118. https://doi.org/10.1016/j.jpag.2014.05.005
The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group, 2012. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). Hum Reprod, 27(1):14–24. https://doi.org/10.1093/humrep/der396
Apter D, Butzow T, Laughlin G, 1993. Hyperandrogenism during Puberty and Adolescence, and Its Relationship to Reproductive Function in the Adult Female. Raven Press, p.265.
Ashoush S, Abou-Gamrah A, Bayoumy H, et al., 2016. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: randomized controlled trial. J Obstet Gynaecol Res, 42(3):279–285. https://doi.org/10.1111/jog.12907
Avvad CK, Holeuwerger R, Silva VC, et al., 2001. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence. Gynecol Endocrinol, 15(3):170–177. https://doi.org/10.1080/713602836
Bazarganipour F, Ziaei S, Montazeri A, et al., 2013. Psychological investigation in patients with polycystic ovary syndrome. Health Qual Life Out, 11:141. https://doi.org/10.1186/1477-7525-11-141
Carmina E, Koyama T, Chang L, et al., 1992. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol, 167(6):1807–1812. https://doi.org/10.1016/0002-9378(92)91779-A
Chen ZJ, Zhang YW, Liu JY, et al., 2011. Diagnosis criteria for polycystic ovary syndrome. Natl Health Fam Plan Commission China, 330:1–7 (in Chinese).
Cosma M, Swiglo BA, Flynn DN, et al., 2008. Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab, 93(4):1135–1142. https://doi.org/10.1210/jc.2007-2429
Cui LL, Zhao H, Zhang B, et al., 2013. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women. Hum Reprod, 28(2):538–544. https://doi.org/10.1093/humrep/des424
Dunaif A, Segal KR, Shelley DR, et al., 1992. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes, 41(10):1257–1266. https://doi.org/10.2337/diabetes.41.10.1257
Ehrmann DA, Barnes RB, Rosenfield RL, et al., 1999. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabet Care, 22(1):141–146. https://doi.org/10.2337/diacare.22.1.141
Endocrinology Group, Obstetrics and Gynecology Committee, China Medical Association, 2008. Consensus on the diagnosis and treatment for polycystic ovary syndrome. Chin J Obstet Gynecol, 43(7):553–555 (in Chinese).
Fauser BC, Tarlatzis BC, Rebar RW, et al., 2012. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril, 97(1): 28–38. https://doi.org/10.1016/j.fertnstert.2011.09.024
Foroozanfard F, Jamilian M, Jafari Z, et al., 2015. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabet, 123(04):215–220. https://doi.org/10.1055/s-0035-1548790
Galletly C, Moran L, Noakes M, et al., 2007. Psychological benefits of a high-protein, low-carbohydrate diet in obese women with polycystic ovary syndrome—a pilot study. Appetite, 49(3):590–593. https://doi.org/10.1016/j.appet.2007.03.222
Ghaneei A, Jowkar A, Ghavam MRH, et al., 2015. Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia. Iran J Reprod Med, 13(2):93–100.
Goldzieher JW, Axelrod LR, 1963. Clinical and biochemical features of polycystic ovarian disease. Fertil Steril, 14(6): 631–653. https://doi.org/10.1016/S0015-0282(16)35047-6
Harborne L, Fleming R, Lyall H, et al., 2003. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab, 88(9):4116–4123. https://doi.org/10.1210/jc.2003-030424
Harrison CL, Lombard CB, Moran LJ, et al., 2011. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update, 17(2):171–183. https://doi.org/10.1093/humupd/dmq045
Joham AE, Teede HJ, Ranasinha S, et al., 2015. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large communitybased cohort study. J Womens Health, 24(4):299–307. https://doi.org/10.1089/jwh.2014.5000
Laven JS, Mulders AGMGJ, Visser JA, et al., 2004. Antimullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab, 89(1):318–323. https://doi.org/10.1210/jc.2003-030932
Legro RS, Kunselman AR, Dodson WC, et al., 1999. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab, 84(1):165–169. https://doi.org/10.1210/jcem.84.1.5393
Legro RS, Arslanian SA, Ehrmann DA, et al., 2013. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 98(12):4565–4592. https://doi.org/10.1210/jc.2013-2350
Legro RS, Brzyski RG, Diamond MP, et al., 2014. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med, 371(2):119–129. https://doi.org/10.1056/NEJMoa1313517
Li R, Zhang Q, Yang D, et al., 2013. Prevalence of polycystic ovary syndrome in women in China: a large communitybased study. Hum Reprod, 28(9):2562–2569. https://doi.org/10.1093/humrep/det262
Lobo RA, Granger LR, Paul WL, et al., 1983. Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. Am J Obstet Gynecol, 145(4): 496–503. https://doi.org/10.1016/0002-9378(83)90324-1
Luque-Ramirez M, Alpanes M, Sanchon R, et al., 2015. Referral bias in female functional hyperandrogenism and polycystic ovary syndrome. Eur J Endocrinol, 173(5): 603–610. https://doi.org/10.1530/EJE-15-0646
McCook JG, Bailey BA, Williams SL, et al., 2015. Differential contributions of polycystic ovary syndrome (PCOS) manifestations to psychological symptoms. J Behav Health Serv Res, 42(3):383–394. https://doi.org/10.1007/s11414-013-9382-7
Melo AS, Ferriani RA, Navarro PA, 2015. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics, 70(11):765–769. https://doi.org/10.6061/clinics/2015(11)09
Merkin SS, Phy JL, Sites CK, et al., 2016. Environmental determinants of polycystic ovary syndrome. Fertil Steril, 106(1):16–24. https://doi.org/10.1016/j.fertnstert.2016.05.011
Milewicz A, 2013. Reimbursement of metformin for polycystic ovary syndrome. Endokrynol Pol, 64(5):409–414. https://doi.org/10.5603/EP.2013.0025
Moll GW, Rosenfield RL, 1983. Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. J Pediatr, 102(3):461–464. https://doi.org/10.1016/S0022-3476(83)80678-7
Moran LJ, Hutchison SK, Norman RJ, et al., 2011. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev, 7: CD007506. https://doi.org/10.1002/14651858.CD007506.pub3
Morgante G, Cappelli V, di Sabatino A, et al., 2015. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association. Minerva Ginecol, 67(5): 457–463.
Nandalike K, Agarwal C, Strauss T, et al., 2012. Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome. Sleep Med, 13(10):1307–1312. https://doi.org/10.1016/j.sleep.2012.07.002
Nidhi R, Padmalatha V, Nagarathna R, et al., 2012. Effect of a yoga program on glucose metabolism and blood lipid levels in adolescent girls with polycystic ovary syndrome. Int J Gynaecol Obstet, 118(1):37–41. https://doi.org/10.1016/j.ijgo.2012.01.027
Norman RJ, Mahabeer S, Masters S, 1995. Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. Fertil Steril, 63(1):58–62. https://doi.org/10.1016/S0015-0282(16)57297-5
Norman RJ, Dewailly D, Legro RS, et al., 2007. Polycystic ovary syndrome. Lancet, 370(9588):685–697. https://doi.org/10.1016/S0140-6736(07)61345-2
Pau CT, Keefe CC, Welt CK, 2013. Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome. Gynecol Endocrinol, 29(6):551–555. https://doi.org/10.3109/09513590.2013.788634
Pigny P, Jonard S, Robert Y, et al., 2006. Serum anti-mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab, 91(3):941–945. https://doi.org/10.1210/jc.2005-2076
Qu F, Li R, Sun W, et al., 2017. Use of electroacupuncture and transcutaneous electrical acupoint stimulation in reproductive medicine: a group consensus. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 18(3):186–193. https://doi.org/10.1631/jzus.B1600437
Rivera R, Yacobson I, Grimes D, 1999. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol, 181(5):1263–1269. https://doi.org/10.1016/S0002-9378(99)70120-1
Roessler KK, Glintborg D, Ravn P, et al., 2012. Supportive relationships—psychological effects of group counselling in women with polycystic ovary syndrome (PCOS). Commun Med, 9(2):125–131.
Rosenfield RL, Ehrmann DA, Littlejohn EE, 2015. Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood. J Clin Endocrinol Metab, 100(4):1537–1543. https://doi.org/10.1210/jc.2014-4290
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004a. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril, 81(1):19–25. https://doi.org/10.1016/j.fertnstert.2003.10.004
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004b. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod, 19(1): 41–47. https://doi.org/10.1093/humrep/deh098
Samimi M, Jamilian M, Ebrahimi FA, et al., 2016. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol, 84(6):851–857. https://doi.org/10.1111/cen.13003
Stabile G, Borrielli I, Artenisio AC, et al., 2014. Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome. J Pediatr Adolesc Gynecol, 27(3):177–182. https://doi.org/10.1016/j.jpag.2013.09.015
Tan S, Hahn S, Benson S, et al., 2008. Psychological implications of infertility in women with polycystic ovary syndrome. Hum Reprod, 23(9):2064–2071. https://doi.org/10.1093/humrep/den227
The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2008a. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril, 89(3):505–522. https://doi.org/10.1016/j.fertnstert.2007.09.041
The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2008b. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod, 23(3):462–477. https://doi.org/10.1093/humrep/dem426
Thomson RL, Buckley JD, Moran LJ, et al., 2009. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. BJOG, 116(9):1242–1250. https://doi.org/10.1111/j.1471-0528.2009.02177.x
Wang F, Pan J, Liu Y, et al., 2015. Alternative splicing of the androgen receptor in polycystic ovary syndrome. Proc Natl Acad Sci USA, 112(15):4743–4748. https://doi.org/10.1073/pnas.1418216112
Wu Y, Robinson N, Hardiman P, et al., 2016. Acupuncture for treating polycystic ovary syndrome: guidance for future randomized controlled trials. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 17(3):169–180. https://doi.org/10.1631/jzus.B1500301
Zhuang J, Liu Y, Xu L, et al., 2014. Prevalence of the polycystic ovary syndrome in female residents of Chengdu, China. Gynecol Obstet Invest, 77(4):217–223. https://doi.org/10.1159/000358485
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Zhejiang Province Science Foundation for Distinguished Young Scholars (No. LR16H040001), the National Natural Science Foundation of China (No. 81401167), the Medical and Health General Project of Zhejiang Province, China (No. 2015KYA122), and the Zhejiang Traditional Chinese Medicine Foundation (Nos. 2017ZQ020 and 2017ZA091), China
Rights and permissions
About this article
Cite this article
Wang, Ff., Pan, Jx., Wu, Y. et al. American, European, and Chinese practice guidelines or consensuses of polycystic ovary syndrome: a comparative analysis. J. Zhejiang Univ. Sci. B 19, 354–363 (2018). https://doi.org/10.1631/jzus.B1700074
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B1700074